Skip to main content
Clinical Trials/CTRI/2023/12/060896
CTRI/2023/12/060896Not yet recruitingPhase 4

A Randomized controlled study to assess the efficacy of ropivacaine instillation through subgaleal drain for postcraniotomy pain

Uttar pradesh university of medical sceinces saifai etawah1 site in 1 country120 target enrollmentStarted: January 5, 2024Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
120
Locations
1
Primary Endpoint
To Assess postoperative pain by NRS (Numeric Rating Scale)

Study Overview

Brief Summary

Title of this study isA randomized controlled study to assess the efficacy         of ropivacaine instillation through subgaleal drain for postcraniotomy pain.

Majority of patients experiences moderate-to-severe pain after craniotomy.Wound instillation of local anaesthetic drugs as a modality for postoperative pain management     has proved quite useful in surgeries such as spine surgeries, laparoscopy, mastectomy, hysterectomy and caesarean section. Various local anaesthetic (LA) drugs such as bupivacaine, levobupivacaine and ropivacaine have been studied for this technique. Ropivacaine is long- acting and exhibits differential blockade predominantly on sensory nerve fibres. It has been successfully and safely used in neurosurgical patients for local infiltration at pin sites, incision site and scalp block. Ropivacaine has better safety profile among all these drugs and had been studied its instillation via subgaleal drains in 0.25% concentration. As there is no study comparing the effect of low concentration of ropivacaine instillation through subgaleal drain so we planned to study the efficacy of low concentrations of ropivacaine such as 0.1% and 0.2% through subgaleal drain for postcraniotomy pain.

Aim of this study is to assess the efficacy of ropivacaine instillation  through subgaleal drain for post craniotomy pain in patients undergoing elective craniotomy.

Objectiveis to assess postoperative pain by NRS (Numeric Rating Scale) and to compare the duration of analgesia.

In this study we will instill the 12ml of 0.1 % and 0.2% ropivacaine through subgaleal drain in post craniotomy patients at the time of dural closure. The patient will be divided into three groups consists of group A (NS), group B (0.1% Ropivacaine), group C ( 0.2% ropivacaine) Then we will assess  the patients for post craniotomy pain through NRS scale, patient satisfaction score.

Outcome measures of this study will assess the post operative pain in patients undergoing elective craniotomy by NRS scale,patient satisfaction score, hemodynamic parameters such as HR, SBP, DBP, MAP,SPO2, RR, Preoperative and postoperative GCS.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • American society of anaesthesiologists (ASA) Physical Status Grade I and II
  • Elective Craniotomy.

Exclusion Criteria

  • Patient refusal
  • Previous Head trauma
  • History of craniotomy
  • Chronic headache (migraine and cluster headache)
  • Glasgow Coma scale (GCS) <13
  • Active psychiatric disorders
  • Allergy to study drugs
  • Chronic opioid/analgesic abuse
  • Chronic steroid use.

Outcomes

Primary Outcomes

To Assess postoperative pain by NRS (Numeric Rating Scale)

Time Frame: From 0 minute to 24 hours

Secondary Outcomes

  • 1.To compare the duration of analgesia.(2.To compare the rescue analgesic requirement in 24 hours postoperatively.)

Investigators

Sponsor
Uttar pradesh university of medical sceinces saifai etawah
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Priyanka Bhardwaj

Uttar pradesh university of medical sciences Saifai, Etawah

Study Sites (1)

Loading locations...

Similar Trials